It was demonstrated in the study that QSYQ decreases plasma TC, TG, and LDL levels and up-regulate LPL expression and plasma HDL levels, which effectively ameliorated dyslipidaemia and decreased AMI risk. The gene discussed is LPL; the disease is inherited lipid metabolism disorder.